Brokers Offer Predictions for ABOS FY2026 Earnings
Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS – Free Report) – Investment analysts at Cantor Fitzgerald issued their FY2026 earnings per share (EPS) estimates for Acumen Pharmaceuticals in a research note issued to investors on Monday, June 9th. Cantor Fitzgerald analyst P. Stavropoulos forecasts that the company will post earnings per share of ($1.21) for the year. The […]
Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS – Free Report) – Investment analysts at Cantor Fitzgerald issued their FY2026 earnings per share (EPS) estimates for Acumen Pharmaceuticals in a research note issued to investors on Monday, June 9th. Cantor Fitzgerald analyst P. Stavropoulos forecasts that the company will post earnings per share of ($1.21) for the year. The […]
